首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   13542篇
  免费   998篇
  国内免费   283篇
耳鼻咽喉   124篇
儿科学   332篇
妇产科学   408篇
基础医学   1369篇
口腔科学   184篇
临床医学   1181篇
内科学   2112篇
皮肤病学   289篇
神经病学   638篇
特种医学   760篇
外国民族医学   8篇
外科学   3333篇
综合类   1453篇
一般理论   1篇
预防医学   319篇
眼科学   107篇
药学   380篇
  8篇
中国医学   42篇
肿瘤学   1775篇
  2023年   225篇
  2022年   317篇
  2021年   519篇
  2020年   611篇
  2019年   516篇
  2018年   546篇
  2017年   486篇
  2016年   521篇
  2015年   461篇
  2014年   841篇
  2013年   854篇
  2012年   627篇
  2011年   713篇
  2010年   640篇
  2009年   682篇
  2008年   675篇
  2007年   670篇
  2006年   606篇
  2005年   551篇
  2004年   504篇
  2003年   389篇
  2002年   348篇
  2001年   272篇
  2000年   197篇
  1999年   178篇
  1998年   169篇
  1997年   140篇
  1996年   151篇
  1995年   143篇
  1994年   133篇
  1993年   120篇
  1992年   113篇
  1991年   114篇
  1990年   98篇
  1989年   85篇
  1988年   72篇
  1987年   59篇
  1986年   51篇
  1985年   82篇
  1984年   53篇
  1983年   35篇
  1982年   43篇
  1981年   43篇
  1980年   37篇
  1979年   33篇
  1978年   27篇
  1977年   27篇
  1976年   13篇
  1975年   7篇
  1970年   6篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Background and aimsThe LISTEN trial (ClinicalTrial.gov accession: NCT01950884) is a phase IV 52 weeks double blind parallel randomized controlled trial that evaluated the effect of ezetimibe plus lifestyle and dietary intervention (eze) vs. lifestyle and dietary intervention alone (placebo) on progression and complications of non-alcoholic steatohepatitis (NASH) evaluated by liver histology.Methods and resultsForty patients with NASH ascertained by histology were randomly allocated on the two study groups and subjected to a follow-up of 52 weeks, when they underwent a second liver biopsy. Main composite end point (EP) was based on the histological improvement in the severity of NASH.Thirty patients completed the study, Eze treatment was not able to improve the primary EP in comparison with placebo, with and odds ratio of 1.029 (0.18–6.38), p = 0.974. Treatment emergent adverse events registered during the study were not more prevalent in the treatment arm.Conclusionsezetimibe administered on top of lifestyle and dietary modification failed to improve the histology of NASH in comparison with lifestyle and dietary modification alone.Trial accession numberClinicalTrial.gov: NCT01950884.  相似文献   
2.
3.
4.
BackgroundIn order to avoid excessive treatment of thyroid nodules in the clinic, it is necessary to find a simple and practical analysis method to comprehensively and accurately reflect benign or malignant thyroid nodules. This study aimed to construct and validate a comprehensive and reliable network-based predictive model using a variety of imaging and laboratory criteria for thyroid nodules to stratify the risk of malignancy prior to surgery.MethodsWe retrospectively analyzed data from patients who underwent surgical treatment for thyroid nodules at the Thyroid and Breast Diagnosis and Treatment Center of Weifang Hospital of Traditional Chinese Medicine between January 2018 and December 2020. Binary logical regression analysis was performed to predict whether nodules were malignant or benign. The developmental dataset included 457 patients (January 2018–December 2020). The validation set included separate data points (n = 225, January 2018–December 2020).ResultsIn this study, criteria that showed significant predictive value for malignant nodules included TI-RADS: 4b (p = 0.065); Bethesda IV, Bethesda V, Bethesda VI (P < 0.0001); BRAFV600E mutation (P < 0.0001); Calcitonin>5 pg/ml (p = 0.0037); and FNA-Tg>30 ng/ml (p = 0.0003). A 10-grade risk scoring system was developed. The risk of malignancy risk ranged from 2.06% to 100% and was positively associated with increasing risk grade. The areas under the receiver-operating characteristic curve of the development and validation sets were 0.972 and 0.946, respectively.ConclusionA simple, comprehensive and reliable web-based predictive model was designed using a variety of imaging and laboratory criteria to stratify thyroid nodules by probability of malignancy.  相似文献   
5.
《Cirugía espa?ola》2023,101(5):325-332
IntroductionIn our institution, the study of selective sentinel node biopsy (SLNB) is performed intraoperatively. The main objective of our study is to know the proportion of patients who benefits from the waiting of the results of SLNB.MethodsA retrospective analysis of patients operated on our center between January 1 st, 2018 and June 30, 2019 was carried out. We included women diagnosed with T1–T2 tumors, treated by lumpectomy and SLNB studied using OSNA method.ResultsOur study included 149 women. There were not statistically significant differences in terms of demographic data between the group treated with axillary lymph node dissection (ALND) and exclusively SLNB group. After analysis of SLN intraoperatively, there were performed 18 axillary lymphadenectomies. Only in six of these 18 cases, three or more sentinel nodes were founded. The location of the tumor, the presence of lymphovascular permeation and the total tumor load (TTL) showed statistically significant differences between groups. Only the TTL was established as the independent factor of the need for ALND.ConclusionsObtaining a deferred result of the SLNB allowed reducing the time of anesthesia and occupation of the operating room, since in a high percentage of cases an additional procedure is not performed.  相似文献   
6.
目的探讨CT引导下经皮肝穿刺活检术在不明原因肝功能异常诊断中的临床应用。方法回顾性分析58例不明原因肝功能异常患者行CT引导下经皮肝穿刺活检术的临床、病理资料,主要观察术后病理诊断率、GS分级诊断率、并发症。结果本组取材成功率100%,手术平均时间11.52 min,取得组织条(1.48±0.50)条,病理诊断率为84.5%(49/58),病理肝炎活动度(G)和肝纤维化程度(S)分级诊断率为72.4%(42/58)。经皮肝穿刺操作未导致肝功能指标数值(ALT、AST、ALP、GGT、TBIL)在短期内显著性增高。8例(13.8%)肝包膜下少量出血,经内科治疗后无进展。结论CT引导下经皮肝穿刺活检术对不明原因肝功能异常的病理及GS分级诊断率高,并发症可控,具有一定的临床应用价值。  相似文献   
7.
目的探讨高频超声检查结合粗针穿刺活检(CNB)在鉴别乳腺癌中的应用及其与血清糖类抗原153(CA153)、CA125的相关性。方法选取138例乳腺肿块患者,经术后病理检查明确为乳腺癌患者71例作为乳腺癌组,67例乳腺良性病变患者为良性乳腺疾病组,比较各组CNB结果以及血清CA125、CA153水平,分析高频超声结合CNB对乳腺癌的诊断价值。结果138例乳腺肿物患者经高频超声引导下CNB病理检查,发现乳腺良性病变69例(50.00%),乳腺癌69例(50.00%),与肿物切除术后病理检查比较,高频超声引导下CNB检查对乳腺癌的鉴别准确率为94.20%,灵敏度92.96%,特异度95.52%。乳腺癌组患者血清糖类抗原125(CA125)、CA153均高于良性乳腺疾病组,差异有统计学意义(P<0.05)。经Pearson相关分析,超声检查显示肿物边界不清晰、形态不规则、内部回声不均匀、CNB检查恶性的乳腺肿块患者血清CA153、CA125的表达高于边界清晰、形态规则、内部回声均匀、CNB检查良性的患者(P<0.05)。结论肿瘤标志物CA125、CA153的表达与乳腺癌超声表现、CNB检查和术后病理结果密切相关,高频超声引导下的CNB可对乳腺癌进行较准确的鉴别,为乳腺肿块患者提供较准确的治疗指导。  相似文献   
8.
9.
10.
ObjectiveTo determine the baseline and cumulative risks of cervical intraepithelial lesion grade 3 (CIN3) and invasive cervical cancer in patients with <CIN2 colposcopy findings after a low-grade screening cytology finding (atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion [LSIL]).MethodsBy linking administrative databases, including cytology, pathology, cancer registries, and physician billing history, a population-based cohort study was performed on participants with <CIN2 initial colposcopy results after a low-grade antecedent cytology finding, between January 2012 and December 2013. Three and 5-year risks of CIN3 and invasive cervical cancer were generated using Kaplan-Meier survival analysis.ResultsAmong the 36 887 participants included in the study, CIN3 incidence based on referral cytology were as follows at 3 and 5 years, respectively: normal, 0.7% and 0.9%; ASCUS, 4.31% and 5.6%; and LSIL, 5.9% and 7.2%. Three- and 5-year incidence of invasive cancer were 0% and 0.02% for normal cytology, 0.08% and 0.11% for ASCUS, and 0.04% and 0.07% for LSIL, respectively. Stratifying risk by biopsy result at initial colposcopy, 3- and 5-year CIN3 incidences were 2.85% and 3.81% with a negative biopsy, 7.09% and 8.32% with an LSIL biopsy, and 4.11% and 5.2% when no biopsy was done, respectively. Three- and 5-year incidence of invasive cancer was 0% and 0.05% after a negative biopsy, 0% and 0% after LSIL biopsy, and 0.05% and 0.08% when no biopsy was done, respectively.ConclusionWhen initial colposcopy is done after a low-grade screening cytology result and <CIN2 is identified, the risk of CIN3 and invasive cancer is low, particularly when biopsies indicate LSIL. Surveillance strategies should balance the likelihood of detecting CIN3 with the potential harms over management with too frequent screening or colposcopic interventions in low-risk patients.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号